115 related articles for article (PubMed ID: 26771938)
1. AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
Hu BR; Fairey AS; Madhav A; Yang D; Li M; Groshen S; Stephens C; Kim PH; Virk N; Wang L; Martin SE; Erho N; Davicioni E; Jenkins RB; Den RB; Xu T; Xu Y; Gill IS; Quinn DI; Goldkorn A
Prostate; 2016 May; 76(6):597-608. PubMed ID: 26771938
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
3. Characterization of RNA-Binding Motif 3 (RBM3) Protein Levels and Nuclear Architecture Changes in Aggressive and Recurrent Prostate Cancer.
Carleton NM; Zhu G; Miller MC; Davis C; Kulkarni P; Veltri RW
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1237. PubMed ID: 32587951
[TBL] [Abstract][Full Text] [Related]
4. Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy.
Ruiz C; Alborelli I; Manzo M; Calgua B; Keller EB; Vuaroqueaux V; Quagliata L; Rentsch CA; Spagnoli GC; Diener PA; Bubendorf L; Morant R; ; Eppenberger-Castori S
Pathobiology; 2023; 90(6):400-408. PubMed ID: 37463569
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.
Eismann L; von Walter P; Jung A; Chaloupka M; Rodler S; Westhofen T; Buchner A; Stief CG; Stadler T; Schlenker B
Urol Oncol; 2023 Jul; 41(7):325.e1-325.e8. PubMed ID: 37179150
[TBL] [Abstract][Full Text] [Related]
6. Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review.
Mendivelso González DF; Sánchez Villalobos SA; Ramos AE; Montero Ovalle WJ; Serrano López ML
Cancer Invest; 2024 Jan; 42(1):75-96. PubMed ID: 38055319
[TBL] [Abstract][Full Text] [Related]
7. Quantification of collagen content and stromal cellularity within reactive stroma is predictive of prostate cancer biochemical recurrence and specific death.
Ding Y; Bu P; Assylbekova B; Ruder S; Miles B; Sayeeduddin M; Lee M; Ayala G
Hum Pathol; 2024 Feb; 144():1-7. PubMed ID: 38159867
[TBL] [Abstract][Full Text] [Related]
8. Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.
Stein J; Krappe E; Kremer A; Cronauer MV; Essler M; Cox A; Klümper N; Krausewitz P; Ellinger J; Ritter M; Kristiansen G; Majores M
J Cancer Res Clin Oncol; 2024 Feb; 150(2):76. PubMed ID: 38310601
[TBL] [Abstract][Full Text] [Related]
9. Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.
Gonnissen A; Isebaert S; Perneel C; McKee CM; Van Utterbeeck F; Lerut E; Verrill C; Bryant RJ; Joniau S; Muschel RJ; Haustermans K
Am J Pathol; 2018 Mar; 188(3):795-804. PubMed ID: 29339090
[TBL] [Abstract][Full Text] [Related]
10. Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H; Gordon R; Li W; Yang X; Pattanayak A; Fowler G; Zhang L; Catalona WJ; Ding Y; Xu L; Huang X; Jovanovic B; Kelly DL; Jiang H; Bergan R
PLoS One; 2019; 14(3):e0214078. PubMed ID: 30917169
[TBL] [Abstract][Full Text] [Related]
11. Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer.
Leite KR; Reis ST; Viana N; Morais DR; Moura CM; Silva IA; Pontes J; Katz B; Srougi M
J Cancer; 2015; 6(3):292-301. PubMed ID: 25663948
[TBL] [Abstract][Full Text] [Related]
12. New insights into the association between
Xu B; Yuan W; Shi L; Zuo L; Wu XY; Zhang W; Wen Q
Cancer Cell Int; 2019; 19():119. PubMed ID: 31080360
[TBL] [Abstract][Full Text] [Related]
13. An Amplified Fatty Acid-Binding Protein Gene Cluster in Prostate Cancer: Emerging Roles in Lipid Metabolism and Metastasis.
Liu RZ; Godbout R
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33352874
[TBL] [Abstract][Full Text] [Related]
14. First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry.
Droz JP; Efstathiou E; Yildirim A; Cabrera P; Soo Kim C; Horchani A; Heidenreich A; Rinck-Junior JA; Hitier S; Ӧzen H
Urol Oncol; 2016 May; 34(5):234.e21-9. PubMed ID: 26777260
[TBL] [Abstract][Full Text] [Related]
15. Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer.
Lee CK; Davies L; Gebski VJ; Lord SJ; Di Leo A; Johnston S; Geyer C; Cameron D; Press MF; Ellis C; Loi S; Marschner I; Simes J; de Souza P
J Clin Oncol; 2016 Mar; 34(9):936-44. PubMed ID: 26811533
[TBL] [Abstract][Full Text] [Related]
16. The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening.
Vickers AJ; Eastham JA; Scardino PT; Lilja H
Urology; 2016 May; 91():12-8. PubMed ID: 26850815
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
18. Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer.
Hussain M; Le Moulec S; Gimmi C; Bruns R; Straub J; Miller K;
Clin Cancer Res; 2016 Jul; 22(13):3192-200. PubMed ID: 26839144
[TBL] [Abstract][Full Text] [Related]
19. Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects.
Mehta AR; Armstrong AJ
Ther Adv Urol; 2016 Feb; 8(1):9-18. PubMed ID: 26834836
[TBL] [Abstract][Full Text] [Related]
20. Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.
Penson DF; Armstrong AJ; Concepcion R; Agarwal N; Olsson C; Karsh L; Dunshee C; Wang F; Wu K; Krivoshik A; Phung D; Higano CS
J Clin Oncol; 2016 Jun; 34(18):2098-106. PubMed ID: 26811535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
